Perimeter Medical Imaging AI, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA71385D1078
CAD
0.18
-0.05 (-20.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Perimeter Medical Imaging AI, Inc. stock-summary
stock-summary
Perimeter Medical Imaging AI, Inc.
Pharmaceuticals & Biotechnology
Perimeter Medical Imaging AI, Inc. is a Canada-based medical device company. The Company develops and commercializes in-procedural medical imaging tools. Its tools enable surgeons, radiologists and pathologists to visualize microscopic tissue structures during a clinical procedure. The Company’s OTIS platform is a point-of-care imaging system that provides clinicians with real-time, sub-surface image volumes of the margin of an excised tissue specimen. OTIS is based on optical coherence tomography (OCT), a technology with commercial applications in ophthalmology and vascular imaging. OTIS scans the specimen in the consumable container during the surgical procedure, with results available for display on the device screen and over the picture archiving and communications systems (PACS), enabling collaboration between surgeon, radiologist and pathologist. The Company is also engaged in developing artificial intelligence and machine learning-enabled image assessment tools.
Company Coordinates stock-summary
Company Details
1 Yonge Street, Suite 201 , TORONTO CA : M5E 1E6
stock-summary
Tel: 1 647 3600302
stock-summary
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-5 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 22 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.29

stock-summary
Return on Equity

-375.97%

stock-summary
Price to Book

3.53